172 related articles for article (PubMed ID: 29743316)
41. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
42. Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.
Bonagura VR; Du Z; Ashouri E; Luo L; Hatam LJ; DeVoti JA; Rosenthal DW; Steinberg BM; Abramson AL; Gjertson DW; Reed EF; Rajalingam R
Hum Immunol; 2010 Feb; 71(2):212-9. PubMed ID: 19861144
[TBL] [Abstract][Full Text] [Related]
43. Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.
Morvan M; Willem C; Gagne K; Kerdudou N; David G; Sébille V; Folléa G; Bignon JD; Retière C
J Immunol; 2009 Jun; 182(11):6727-35. PubMed ID: 19454667
[TBL] [Abstract][Full Text] [Related]
44. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.
Stewart CA; Laugier-Anfossi F; Vély F; Saulquin X; Riedmuller J; Tisserant A; Gauthier L; Romagné F; Ferracci G; Arosa FA; Moretta A; Sun PD; Ugolini S; Vivier E
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13224-9. PubMed ID: 16141329
[TBL] [Abstract][Full Text] [Related]
45. HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.
Goodridge JP; Burian A; Lee N; Geraghty DE
J Immunol; 2013 Oct; 191(7):3553-62. PubMed ID: 24018270
[TBL] [Abstract][Full Text] [Related]
46. Increased frequency of ILT2-expressing CD56(dim)CD16(+) NK cells correlates with disease severity of pulmonary tuberculosis.
Wang X; Meng X; Zheng Y; Jiang J; Yang B; Liu Y; Zhai F; Cheng X
Tuberculosis (Edinb); 2014 Sep; 94(5):469-74. PubMed ID: 24909369
[TBL] [Abstract][Full Text] [Related]
47. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function.
Tremblay-McLean A; Coenraads S; Kiani Z; Dupuy FP; Bernard NF
BMC Immunol; 2019 Jan; 20(1):8. PubMed ID: 30696399
[TBL] [Abstract][Full Text] [Related]
48. Functional analysis of NK cell subsets activated by 721.221 and K562 HLA-null cells.
Lisovsky I; Isitman G; Bruneau J; Bernard NF
J Leukoc Biol; 2015 Apr; 97(4):761-7. PubMed ID: 25713086
[TBL] [Abstract][Full Text] [Related]
49. Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2.
Long BR; Erickson AE; Chapman JM; Barbour JD; Vu BA; Ho EL; Lanier LL; Sauer MM; Carvalho KI; Nixon DF; Kallas EG
Immunology; 2010 Feb; 129(2):186-96. PubMed ID: 19824915
[TBL] [Abstract][Full Text] [Related]
50. KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing.
Carlomagno S; Falco M; Bono M; Alicata C; Garbarino L; Mazzocco M; Moretta L; Moretta A; Sivori S
Front Immunol; 2017; 8():581. PubMed ID: 28603523
[TBL] [Abstract][Full Text] [Related]
51. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
[TBL] [Abstract][Full Text] [Related]
52. HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.
Duygu B; Olieslagers TI; Groeneweg M; Voorter CEM; Wieten L
Front Immunol; 2021; 12():680480. PubMed ID: 34295330
[TBL] [Abstract][Full Text] [Related]
53. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
J Immunol; 2014 Jan; 192(2):732-40. PubMed ID: 24337374
[TBL] [Abstract][Full Text] [Related]
54. Human NK cells: From surface receptors to clinical applications.
Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
[TBL] [Abstract][Full Text] [Related]
55. HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire.
Lauterbach N; Wieten L; Popeijus HE; Voorter CE; Tilanus MG
Hum Immunol; 2015 Aug; 76(8):578-86. PubMed ID: 26382247
[TBL] [Abstract][Full Text] [Related]
56. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
[TBL] [Abstract][Full Text] [Related]
57. A rapid method for assessment of natural killer cell function after multiple receptor crosslinking.
Al-Hubeshy ZB; Coleman A; Nelson M; Goodier MR
J Immunol Methods; 2011 Mar; 366(1-2):52-9. PubMed ID: 21281644
[TBL] [Abstract][Full Text] [Related]
58. The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection.
Lin A; Yan WH
Front Immunol; 2019; 10():964. PubMed ID: 31134067
[TBL] [Abstract][Full Text] [Related]
59. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.
Favier B; Lemaoult J; Lesport E; Carosella ED
FASEB J; 2010 Mar; 24(3):689-99. PubMed ID: 19841038
[TBL] [Abstract][Full Text] [Related]
60. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
